Weight Loss Treatments

These treatments work by mimicking natural gut hormones (like GLP-1 and GIP) that regulate your appetite and blood sugar. They communicate with your brain to make you feel fuller much faster, significantly reduce food cravings, and slow down stomach emptying. This allows you to lose weight sustainably without relying solely on willpower.

Yes. Both Mounjaro and Wegovy are MHRA-approved in the UK for weight management. In clinical trials, patients taking Wegovy lost an average of 15% of their body weight, while patients on Mounjaro achieved up to 22.5% weight loss. They are prescribed by our UK-licensed clinicians only after a thorough medical assessment to ensure they are safe for your specific biology.

As these medications slow gastric emptying, the most common side effects are gastrointestinal. These can include mild nausea, constipation, diarrhea, or acid reflux, particularly when first starting or moving up a dose. These symptoms are usually temporary and subside as your body adjusts. Our clinical team provides full guidance on how to manage and minimize them.

Obesity is increasingly recognized as a chronic metabolic condition. While you will likely see significant results within the first 3 to 6 months, these medications are designed for long-term use. If you stop the medication, your appetite will return and weight regain is common. Many patients choose to stay on a lower maintenance dose long-term to protect their progress.

While both Mounjaro and Wegovy are approved by NICE for use on the NHS, access is currently heavily restricted to specialist tier-3 weight management services, which have years-long waiting lists. Because of this, most patients opt to access these treatments privately through services like Prescriptly to begin their journey immediately.